You are here:
Topiramate: Data concerning the risk of malformations
2011.03.22
Active substance: topiramate
Based on evaluations from pregnancy registries, the USA has now also revised the product informations of medicinal products containing topiramate and has included corresponding warnings already implemented in European marketing authorisations.
risk information - full text (available in German only)